Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Federal Trade Commission
Chinese Patent Office

Generated: December 17, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

When do Methylphenidate Hydrochloride patents expire, and what generic alternatives are available?

Methylphenidate Hydrochloride is a drug marketed by Barr Labs Inc, Impax Labs Inc, Mallinckrodt Inc, Mayne Pharma, Teva Pharms, Abhai Llc, Breckenridge Pharm, Novel Labs Inc, Tris Pharma Inc, Tedor Pharma Inc, Able, Actavis Elizabeth, Cnty Line Pharms, Kremers Urban Pharms, Mylan Pharms Inc, Osmotica, Watson Labs, Abhai Inc, Actavis Labs Fl Inc, Ascent Pharms Inc, Mallinckrodt, Sun Pharm Inds Inc, Ucb Inc, and Vintage Pharms. and is included in thirty-eight NDAs.

The generic ingredient in METHYLPHENIDATE HYDROCHLORIDE is methylphenidate hydrochloride. There are thirty-one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
Drug patent expirations by year for METHYLPHENIDATE HYDROCHLORIDE


US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abhai IncMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET;ORAL206932-002May 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET;ORAL090710-001Mar 15, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Tedor Pharma IncMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET, CHEWABLE;ORAL205756-001Nov 7, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs IncMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideSOLUTION;ORAL204602-002Aug 14, 2015AARXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge PharmMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET;ORAL207587-001Mar 3, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Cnty Line PharmsMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL204772-002Feb 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt IncMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL202608-003Dec 28, 2012BXRXNoNo► Subscribe► Subscribe► Subscribe
Abhai LlcMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL207488-002Jun 9, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET;ORAL090710-002Mar 15, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs IncMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL208607-001Jul 14, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: